Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia

Among 354 participants with fibromyalgia, 29.9% reported past use of a psychedelic.

• Lysergic acid diethylamide (LSD) and psilocybin mushrooms were the most commonly used psychedelics.
• Perceptions of benefit from psychedelic use were mostly neutral (59.4%) or positive (36.8%).
• Fewer than 3% of participants reported negative impacts on overall health or pain symptoms from psychedelic use.
• Of the 12 participants who used psychedelics to treat chronic pain, 11 reported improved symptoms.
• The majority of participants believed that psychedelics could be effective for chronic pain treatments.
• Many participants expressed willingness to participate in a clinical trial involving psychedelic-based treatments.

AI simplified